RVAC Medicines
PrivateLast Round
Series B
Apr 26, 2022
Est. Valuation
$560M
Total Funding Raised
$140M
Company Overview
RVAC Medicines operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series B round in April 2022.
RVAC Medicines is a biotechnology company that develops an mRNA platform to build a diverse pipeline of innovative vaccines and therapeutics to address unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RVAC Medicines Comparables
Compare RVAC Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innorna | 88% | |
| Immorna Biotherapeutics | 83% | |
| Strand Therapeutics | 79% |
For institutional investors. Book with your work email.
RVAC Medicines Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
RVAC Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CBC Group | Series B |
| EDBI | Series B |
| Pavilion Capital | Series B |
| Pavilion Capital | Series B |
| GS Holdings | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 26, 2022
$140M round led by CBC Group
For institutional investors. Book with your work email.
RVAC Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RVAC Medicines's valuation, stock price, and market status.
Is RVAC Medicines a public or private company?
RVAC Medicines is a private company.
What is the current stock price of RVAC Medicines?
RVAC Medicines is a private company, so its shares have no public market price. Caplight tracks RVAC Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RVAC Medicines worth (valuation)?
RVAC Medicines's valuation is estimated at $560.0M based on funding round data.
Can I buy RVAC Medicines stock?
RVAC Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RVAC Medicines's last funding round?
RVAC Medicines's most recent funding round was Series B on April 26, 2022.
Who are the main investors in RVAC Medicines?
Key investors in RVAC Medicines include CBC Group.
Will RVAC Medicines IPO soon?
No public IPO plans have been announced for RVAC Medicines.
How can I track RVAC Medicines secondary market activity?
Caplight tracks bids, offers, and trades in RVAC Medicines's shares on secondary markets.